- Hypothesis of study: the investigators expect that PIPAC is a safe, feasible, and tolerable treatment for patients with peritoneal metastases of colorectal cancer, with a potentially similar or higher efficacy against peritoneal metastases of colorectal cancer compared to chemotherapy through the veins.